News
The Innovation and Business Development Unit of IDIBELL participates in the largest congress of biotechnology industries in Europe
This is the most important event of the biotechnology, pharmaceutical, and financial industry specialized in life sciences in Europe
Sinergia 2021: the return of live science activities and release of new audiovisual content
The third edition of the L’Hospitalet health research and innovation festival will be held from 15 to 20 November, coinciding with the 26th Science Week. Live activities will take place at the Duran i Reynals Hospital and the Harmonia building in L’Hospitalet.
A new stent improves the treatment of coronary heart disease in people with diabetes
Its greater effectiveness has been verified in a study coordinated by the Bellvitge Hospital and IDIBELL. The new device reduces the number of serious complications by 35% one year after the intervention. The study was published in the world’s leading cardiovascular journal.
The study of genetic variants for the early detection of colorectal cancer: current state and future perspectives
An IDIBELL and ICO study determines that the set of genetic variants has an important role in the evolution of colorectal cancer. However, it is still too soon to use them as the single tool for screening and early detection of colorectal cancer.
Identification of a new mitochondrial syndrome characterized by multisystemic involvement
“The genetic identification of this new disease will facilitate a faster diagnosis in the future, which will allow offering precise genetic counseling and clinical management,” highlights Aurora Pujol.
Described new predictors of mortality in severe pulmonary embolism
A study carried out by researchers from IDIBELL and the Bellvitge University Hospital has described new predictors of mortality in the endovascular treatment of severe pulmonary embolism.
Breast cancer cells create collagen shields to protect themselves from the immune system
A study published in Nature with the participation of IDIBELL and ICO shows that a protein on the surface of mammary tumor cells binds to extracellular collagen and aligns it to block the entry of immune cells.
Dr. Joan Fabregat receives the Virgili Award from the Catalan Society of Surgery
Dr. Joan Fabregat Prous, a principal investigator of the IDIBELL hepato-biliary-pancreatic pathology research group and head of the section of the General and Digestive Surgery Service of the Bellvitge University Hospital, received the “Pere Virgili Award” on October 14th. The event took place at the Royal Academy of Medicine of Catalonia.
A team of neuroscientist from IDIBELL performed an experiment about musical curiosity at Sónar+D
Music plays a key role in our lives: it has the inherent ability to evoke a wide range of emotions and feelings and it is used as a powerful mood regulator. But strong individual differences have been observed in the intrinsic motivation to look for new music and enjoy it. For example, while some people […]